Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribonuclease H1 (RNase H1) is a non-sequence-specific endonuclease enzyme found in prokaryotes and eukaryotes, encoded in humans by the RNASEH1 gene. It specifically cleaves the RNA strand of RNA/DNA hybrids through a hydrolytic mechanism, playing a crucial role in the removal of RNA from such hybrids, most notably in the context of R-loop structures that form during transcription and replication. RNase H1 maintains genome stability by preventing the accumulation of these hybrids, which can otherwise lead to genomic instability. Structurally, the enzyme contains a characteristic DEDD active site motif, requiring magnesium ions for catalysis. Its activity has been harnessed therapeutically, particularly in antisense oligonucleotide (ASO) therapies targeting disease-associated RNA. RNase H1 dysfunction is associated with impaired DNA repair, increased R-loop formation, and is implicated as a regulatory factor in some cancer types[1][2][3][5][8].
Hydrolytic cleavage of RNA in RNA/DNA duplexes Removal of RNA from RNA-DNA hybrids formed during DNA replication, repair, and transcription
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribonuclease H1 (RNase H1).